BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: Implications for hereditary hemorrhagic telangiectasia type II

Angiogenesis

Volumn 15, Issue 3, 2012, Pages 497-509

  Kim, Jai Hyun ^a   Peacock, Matthew R ^a   George, Steven C ^a,b,c   Hughes, Christopher C W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California at Irvine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alk1; Angiogenesis; Arteriovenous malformation; AVM; BMP9; HHT2; VEGFR2

Indexed keywords

ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR LIKE KINASE 1; BONE MORPHOGENETIC PROTEIN 9; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; EPHRIN B2; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 3; NOTCH RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ACVRL1 GENE; ANASTOMOSIS; ANGIOGENESIS; ARTERIOVENOUS MALFORMATION; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HEREDITARY HEMORRHAGIC TELANGIECTASIA TYPE II; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INDUCTION; RECEPTOR GENE; SIGNAL TRANSDUCTION; TELANGIECTASIA;

ACTIVIN RECEPTORS, TYPE I; ACTIVIN RECEPTORS, TYPE II; ANIMALS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; DNA PRIMERS; ENDOTHELIUM, VASCULAR; EPHRIN-B2; GROWTH DIFFERENTIATION FACTOR 2; INHIBITOR OF DIFFERENTIATION PROTEINS; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 84865118378     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9277-x     Document Type: Article

References (58)

1. HHT Foundation International website (2011)
2. Shovlin CL (2010) Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 24(6):203-219
3. Govani FS, Shovlin CL (2009) Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 17(7):860-871. PMCID: 2986493
4. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13(2):189-195 (Pubitemid 26000439)
5. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE et al (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8(4):345-351
6. Barbara NP, Wrana JL, Letarte M (1999) Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem 274(2):584-594 (Pubitemid 29058021)
7. Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, Bernabeu C (2005) Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex. J Cell Physiol 204(2):574-584 (Pubitemid 40934653)
8. Park SO, Wankhede M, Lee YJ, Choi EJ, Fliess N, Choe SW et al (2009) Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J Clin Invest 119(11):3487-3496. PMCID: 2769195
9. Bonyadi M, Rusholme SA, Cousins FM, Su HC, Biron CA, Farrall M et al (1997) Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. Nat Genet 15(2):207-211 (Pubitemid 27061646)
10. Bourdeau A, Faughnan ME, McDonald ML, Paterson AD, Wanless IR, Letarte M (2001) Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. Am J Pathol 158(6):2011-2020. PMCID: 1891990
11. Seki T, Yun J, Oh SP (2003) Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 93(7):682-689 (Pubitemid 37222165)
12. David L, Feige JJ, Bailly S (2009) Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20(3):203-212
13. David L, Mallet C, Keramidas M, Lamande N, Gasc JM, Dupuis-Girod S et al (2008) Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 102(8):914-922 (Pubitemid 351591550)
14. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109(5):1953-1961 (Pubitemid 46348192)
15. Holderfield MT, Hughes CC (2008) Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ Res 102(6):637-652 (Pubitemid 351457853)
16. Brown MA, Zhao Q, Baker KA, Naik C, Chen C, Pukac L et al (2005) Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem 280(26):25111-25118 (Pubitemid 40934603)
17. Pardali E, Goumans MJ, ten Dijke P (2010) Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol 20(9):556-567
18. Park SO, Lee YJ, Seki T, Hong KH, Fliess N, Jiang Z et al (2008) ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 111(2):633-642. PMCID: 2200847
19. Seki T, Hong KH, Oh SP (2006) Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development. Lab Invest A J Tech Methods Pathol 86(2):116-129 (Pubitemid 43117592)
20. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21(7):1743-1753 (Pubitemid 34614630)
21. Lamouille S, Mallet C, Feige JJ, Bailly S (2002) Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100(13):4495-4501 (Pubitemid 35429690)
22. Lux A, Salway F, Dressman HK, Kroner-Lux G, Hafner M, Day PJ et al (2006) ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression. BMC Cardiovasc Disord 6:13 (Pubitemid 44202717)
23. Mallet C, Vittet D, Feige JJ, Bailly S (2006) TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5. Stem Cells 24(11):2420-2427 (Pubitemid 44674302)
24. Ota T, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H et al (2002) Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells. J Cell Physiol 193(3):299-318 (Pubitemid 35265950)
25. Goumans MJ, Lebrin F, Valdimarsdottir G (2003) Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med 13(7):301-307 (Pubitemid 37159396)
26. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK et al (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Nat Acad Sci USA 97(6):2626-2631 (Pubitemid 30159221)
27. Roman BL, Pham VN, Lawson ND, Kulik M, Childs S, Lekven AC et al (2002) Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels. Development 129(12):3009-3019 (Pubitemid 34874278)
28. Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L et al (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120(Pt 6):964-972 (Pubitemid 46638511)
29. Urness LD, Sorensen LK, Li DY (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26(3):328-331
30. Upton PD, Davies RJ, Trembath RC, Morrell NW (2009) Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells. J Biol Chem 284(23):15794-15804. PMCID: 2708876
31. Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM et al (2001) Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230(2):151-160 (Pubitemid 32171414)
32. Shin D, Garcia-Cardena G, Hayashi S, Gerety S, Asahara T, Stavrakis G et al (2001) Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol 230(2):139-150 (Pubitemid 32171413)
33. Krebs LT, Starling C, Chervonsky AV, Gridley T (2010) Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants. Genesis 48(3):146-150. PMCID: 2849749
34. Bochenek ML, Dickinson S, Astin JW, Adams RH, Nobes CD (2010) Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding. J Cell Sci 123(Pt 8):1235-1246. PMCID: 2848112
35. Heroult M, Schaffner F, Pfaff D, Prahst C, Kirmse R, Kutschera S et al (2010) EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinb2. Mol Cancer Res MCR 8(10):1297-1309
36. Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu ME, Acker T et al (2010) Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 465(7297):487-491
37. Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A et al (2010) Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465(7297):483-486
38. Nakatsu MN, Sainson RC, Aoto JN, Taylor KL, Aitkenhead M, Perez-del-Pulgar S et al (2003) Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1 small star, filled. Microvasc Res 66(2):102-112 (Pubitemid 36962872)
39. Kim JH, Zhao Y, Pan X, He X, Gilbert HF (2009) The unfolded protein response is necessary but not sufficient to compensate for defects in disulfide isomerization. J Biol Chem 284(16):10400-10408. PMCID: 2667727
40. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R et al (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts [see comments]. Nature 401(6754):670-677 (Pubitemid 29485206)
41. Sainson RC, Aoto J, Nakatsu MN, Holderfield M, Conn E, Koller E et al (2005) Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB J 19(8):1027-1029 (Pubitemid 40827740)
42. Newman AC, Nakatsu MN, Chou W, Gershon PD, Hughes CC (2011) The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol Biol Cell 22(20):3791-3800. PMCID: 3192859
43. David L, Mallet C, Vailhe B, Lamouille S, Feige JJ, Bailly S (2007) Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. J Cell Physiol 213(2):484-489 (Pubitemid 47509730)
44. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U et al (1999) Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13(3):295-306 (Pubitemid 29095801)
45. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A et al (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161(6):1163-1177 (Pubitemid 36870177)
46. Henderson AM, Wang SJ, Taylor AC, Aitkenhead M, Hughes CC (2001) The basic helix-loop-helix transcription factor HESR1 regulates endothelial cell tube formation. J Biol Chem 276(9):6169-6176
47. Holderfield MT, Henderson Anderson AM, Kokubo H, Chin MT, Johnson RL, Hughes CC (2006) HESR1/CHF2 suppresses VEGFR2 transcription independent of binding to E-boxes. Biochem Biophys Res Commun 346(3):637-648
48. Taylor KL, Henderson AM, Hughes CC (2002) Notch Activation during Endothelial Cell Network Formation in Vitro Targets the Basic HLH Transcription Factor HESR-1 and Downregulates VEGFR-2/KDR Expression. Microvasc Res 64(3):372-383 (Pubitemid 35370739)
49. Carlson TR, Yan Y, Wu X, Lam MT, Tang GL, Beverly LJ et al (2005) Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc Natl Acad Sci 102(28):9884-9889. PMCID: 1175015
50. Leblanc GG, Golanov E, Awad IA, Young WL (2009) Biology of vascular malformations of the brain. Stroke 40(12):e694-e702. PMCID: 2810509
51. Swift MR, Weinstein BM (2009) Arterial-venous specification during development. Circ Res 104(5):576-588
52. ZhuGe Q, Zhong M, Zheng W, Yang GY, Mao X, Xie L et al (2009) Notch-1 signalling is activated in brain arteriovenous malformations in humans. Brain 132(Pt 12):3231-3241. PMCID: 2792368
53. Dejana E, Tournier-Lasserve E, Weinstein BM (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16(2):209-221
54. Marchuk DA, Srinivasan S, Squire TL, Zawistowski JS (2003) Vascular morphogenesis: tales of two syndromes. Hum Mol Genet 12 Spec No 1:R97-R112
55. Morikawa M, Koinuma D, Tsutsumi S, Vasilaki E, Kanki Y, Heldin CH et al (2011) ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res 39(20):8712-8727. PMCID: 3203580
56. Corti P, Young S, Chen CY, Patrick MJ, Rochon ER, Pekkan K et al (2011) Interaction between alk1 and blood flow in the development of arteriovenous malformations. Development 138(8):1573-1582. PMCID: 3062425
57. Suzuki Y, Ohga N, Morishita Y, Hida K, Miyazono K, Watabe T (2010) BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo. J Cell Sci 123(Pt 10):1684-1692
58. Davidson TM, Olitsky SE, Wei JL (2010) Hereditary hemorrhagic telangiectasia/avastin. The Laryngoscope 120(2):432-435